GlassScriptPhysician profile
Atsushi Endo
NPI 1366517005
$18,587.51
in general payments reported to CMS, 2019-2025
12 companies · $1,472 in 2025
The $1,472 reported for 2025 was more than what 92% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,064 · 2020: $147 · 2021: $5,466 · 2022: $6,256 · 2023: $199 · 2024: $984 · 2025: $1,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018 · Travel and Lodging: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,018.06 |
| Travel and Lodging | $636.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,515.13 | 2021-2025 | |
| Smith+Nephew, INC. | $3,793.75 | 2019-2025 | Spatial Frame, Smart Tsf, Taylor Spatial Frame |
| Exactech, INC. | $1,693.61 | 2019-2021 | |
| Stryker Corporation | $1,679.67 | 2021-2025 | Inbone, Infinity, Inspace |
| Kairos Surgical INC | $1,365.13 | 2021-2024 | |
| Paragon 28, INC. | $1,303.33 | 2021-2025 | Phantom Fibula Nail |
| Globus Medical, INC. | $67.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $45.88 | 2024 | Trabecular Metal |
| Aroa Biosurgery Incorporated | $42.11 | 2025 | |
| Biocomposites INC | $35.62 | 2025 | Stimulan |
| Life Spine, INC. | $34.31 | 2022 | |
| Next Science LLC | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atsushi Endo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.